Cancer Cell
Volume 22, Issue 5, 13 November 2012, Pages 571-584
Journal home page for Cancer Cell

Article
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation

https://doi.org/10.1016/j.ccr.2012.08.013Get rights and content
Under an Elsevier user license
open archive

Summary

A large proportion of colorectal cancers (CRCs) display mutational inactivation of the TGF-β pathway, yet, paradoxically, they are characterized by elevated TGF-β production. Here, we unveil a prometastatic program induced by TGF-β in the microenvironment that associates with a high risk of CRC relapse upon treatment. The activity of TGF-β on stromal cells increases the efficiency of organ colonization by CRC cells, whereas mice treated with a pharmacological inhibitor of TGFBR1 are resilient to metastasis formation. Secretion of IL11 by TGF-β-stimulated cancer-associated fibroblasts (CAFs) triggers GP130/STAT3 signaling in tumor cells. This crosstalk confers a survival advantage to metastatic cells. The dependency on the TGF-β stromal program for metastasis initiation could be exploited to improve the diagnosis and treatment of CRC.

Highlights

► TGF-β pathway mutant cells require a stromal TGF-β program for metastasis ► CRC patients with low levels of stromal TGF-β program do not relapse ► Pharmacological blockade of TGF-β stromal signaling prevents metastasis initiation ► A TGF-β/IL-11/GP130 signaling cycle confers metastatic organ colonization capacity

Cited by (0)

11

These authors contributed equally to this work